Correction: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Authors: Caleb P. Skipper, MD, Katelyn A. Pastick, BSc, Nicole W. Engen, MS, Ananta S. Bangdiwala, MS, Mahsa Abassi, DO, MPH
Journal: Annals of Internal Medicine (2021)

CorrectionsMarch 2021Correction: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19FREEThis correction concerns the following article:Original ResearchOct 2020Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19FREECaleb P. Skipper, MD, Katelyn A. Pastick, BSc, Nicole W. Engen, MS, Ananta S. Bangdiwala, MS, Mahsa Abassi, DO, MPHCaleb P. Skipper, MDUniversity of Minnesota, Minneapolis, Minnesota (C.P.S., K.A.P., N.W.E., A.S.B., M.A., S.M.L., D.A.W., E.C.O., M.F.P., M.R.N., A.A.N., K.H.H., R.R., D.R.B.), Katelyn A. Pastick, BScUniversity of Minnesota, Minneapolis, Minnesota (C.P.S., K.A.P., N.W.E., A.S.B., M.A., S.M.L., D.A.W., E.C.O., M.F.P., M.R.N., A.A.N., K.H.H., R.R., D.R.B.), Nicole W. Engen, MSUniversity of Minnesota, Minneapolis, Minnesota (C.P.S., K.A.P., N.W.E., A.S.B., M.A., S.M.L., D.A.W., E.C.O., M.F.P., M.R.N., A.A.N., K.H.H., R.R., D.R.B.), Ananta S. Bangdiwala, MSUniversity of Minnesota, Minneapolis, Minnesota (C.P.S., K.A.P., N.W.E., A.S.B., M.A., S.M.L., D.A.W., E.C.O., M.F.P., M.R.N., A.A.N., K.H.H., R.R., D.R.B.), Mahsa Abassi, DO, MPHUniversity of Minnesota, Minneapolis, Minnesota (C.P.S., K.A.P., N.W.E., A.S.B., M.A., S.M.L., D.A.W., E.C.O., M.F.P., M.R.N., A.A.N., K.H.H., R.R., D.R.B.)https://doi.org/10.7326/L20-1220 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In the article by Skipper and colleagues (1), there was a typo in Supplement Table 2 regarding medication adherence. One of the labels in the first column was listed as “< 75% (1-14 tablets)” and has been corrected to “< 75% (0-14 tablets).” This is still <75% adherence, and the breakdown is displayed in Supplement Table 3. These corrections were made to the online version on 8 October 2020.Reference1. Skipper CP, Pastick KA, Engen NW, et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19. A randomized trial. Ann Intern Med. 2020;173:623-31. doi:10.7326/M20-4207 LinkGoogle Scholar Comments0 CommentsSign In to Submit A Comment PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHydroxychloroquine in Nonhospitalized Adults With Early COVID-19 Caleb P. Skipper , Katelyn A. Pastick , Nicole W. Engen , Ananta S. Bangdiwala , Mahsa Abassi , Sarah M. Lofgren , Darlisha A. Williams , Elizabeth C. Okafor , Matthew F. Pullen , Melanie R. Nicol , Alanna A. Nascene , Kathy H. Hullsiek , Matthew P. Cheng , Darlette Luke , Sylvain A. Lother , Lauren J. MacKenzie , Glen Drobot , Lauren E. Kelly , Ilan S. Schwartz , Ryan Zarychanski , Emily G. McDonald , Todd C. Lee , Radha Rajasingham , and David R. Boulware Metrics Cited byThe development of COVID-19 treatmentUse of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis March 2021Volume 174, Issue 3Page: 435 ePublished: 16 March 2021 Issue Published: March 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...